companydata.dkNordre Fasanvej 216 Komplementarselskab ApS: Financial statements 2024
CVR: 41236078
Nordre Fasanvej 216 Komplementarselskab ApS (CVR 41236078) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 250 and a net result of DKK 752 compared with DKK 0 the year before. Equity amounted to DKK 33,832. The solvency ratio was 91.1%.
- Gross Profit
- 250 kr.
- Profit/Loss
- 752 kr.
- Equity
- 33,832 kr.
- Total Assets
- 37,155 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 250 | 752 | 34 t. | 0 |
| 2023 | 0 | -3 t. | 0 | 33 t. | - |
| 2022 | - | -3 t. | 0 | 33 t. | - |
| 2021 | - | -3 t. | 0 | 33 t. | - |
How creditworthy is Nordre Fasanvej 216 Komplementarselskab ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Nordre Fasanvej 216 Komplementarselskab ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 0.
About Nordre Fasanvej 216 Komplementarselskab ApS
Nordre Fasanvej 216 Komplementarselskab ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Erik Wihlborg. The company's owners include ARKMEDIC ApS, Lene Agersnap and Morten Haaning Charles. In 2025, the company reported a gross profit of DKK 875 and a net result of DKK 1,226 compared with DKK 752 the year before. Equity amounted to DKK 35,058.